Drug Approval | June 14, 2022
FDA accepts application for Merck’s Keytruda as adjuvant therapy for Stage IB-IIIA lung cancer
Acceptance based on results from the phase 3 KEYNOTE-091 trial
Acceptance based on results from the phase 3 KEYNOTE-091 trial
India’s first oncology laboratory for comprehensive Cancer Diagnostic services
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
Dupixent is the first and only biologic medicine approved to treat moderate-to-severe atopic dermatitis from infancy to adulthood
A big boost to healthcare efforts of Ayush through NARIP, CCRAS
New Regional Processing Lab will serve Ahmedabad and the state of Gujarat
AstraZeneca also played a critical role in the global response to COVID-19.
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
As per partnership, Carbanio will arrange raw materials and other custom chemicals for Proexp Pharma Pvt. Ltd. through an uninterrupted digital process of the company
Subscribe To Our Newsletter & Stay Updated
